Skip to main content
June 2023 Research Awards

June 2023 Research Awards

Investigator Sponsor Type Project Title Begin Date End Date Awarded Dollars
Sabrina Absalon Grace M. Showalter Trust New MCMCBP: a guardian of genome integrity during P. falciparum asexual replication. 7/1/2023 6/30/2024 $75,000.00
Gianfranco Alpini Texas A&m University New Regulation of Ductular Reaction by Substance P during Alcohol-induced Liver Injury 4/1/2023 3/31/2024 $105,757.00
Daria Barwinska Grace M. Showalter Trust New Assessment of the role of CD90+ proximal tubule cells in adaptive kidney repair in health and disease. 7/1/2023 6/30/2024 $75,000.00
Melissa K Bear Riley Children's Foundation New Chemotherapy research for babies with SCID to achieve good immunity 5/1/2022 11/30/2024 $25,000.00
Helen Bernie Boston Scientific Foundation New Indiana University - Male Sexual and Reproductive Medicine Fellowship 7/1/2023 6/30/2024 $50,000.00
Ashay D Bhatwadekar Grace M. Showalter Trust New 2023 IUSM Showalter Scholar - Ashay Bhatwadekar 7/1/2023 6/30/2024 $25,000.00
Paul G Biondich Regenstrief Institute, Inc. Renewal (not prev committed) Data for Accountability, Transparency and Impact Monitoring (DATIM) External Systems Support 1/1/2023 12/31/2023 $410,531.00
Cynthia L Bodkin Massachusetts General Hospital New HEALEY ALS Platform Trial Regimen G 5/30/2023 5/29/2028 $234,840.00
Malaz A Boustani Albert Einstein College Of Medicine New 5- Cog Battery to Improve Detection of Cognitive Impairment and Dementia: Pragmatic Clinical Trial 9/17/2022 8/31/2023 $1,185,492.00
Jared Robert Brosch University Of Southern California New Alzheimer's Disease Neuroimaging Initiative (ADNI4) 9/15/2022 7/31/2023 $1,200,000.00
Randy R Brutkiewicz U.s. Army Medical Research Acquisition Activity New Prevention of posttraumatic epilepsy by inhibiting the initiation of innate immune reaction 7/1/2023 6/30/2026 $1,299,999.00
Saira Butt Health And Hospital Corporation Of Marion County Renewal (not prev committed) Title XXVI HIV Health Care Services Program 1, 2 Part A, Emergency Relief for Areas with Substantial Need for Services 3/1/2023 2/29/2024 $28,049.00
Christopher M. Callahan Regenstrief Institute, Inc. Renewal (not prev committed) Regenstrief 44-825-70 7/1/2023 6/30/2024 $1,381,273.00
Eugene P Ceppa Northshore University Healthsystem New The Laparoscopic In Biliary Exploration Research and Training Initiative (LIBERTI) Study 5/31/2023 5/30/2028 $9,000.00
Qiuyan Chen Grace M. Showalter Trust New Structural Basis of Cancer Metastasis Mediated by Arrestin2 and STAM1 7/1/2023 6/30/2024 $75,000.00
Zhenhui Chen American Heart Association Incorporated New Critical pathways for distribution of phospholemman and the Na, K-ATPase protein complex in cardiomyocytes. 7/1/2023 6/30/2026 $299,999.70
Zhenhui Chen National Heart, Lung And Blood Institute New Critical Sorting Steps and Pathways in the Trafficking of Cardiac Sarcoplasmic Reticulum Proteins 6/15/2023 3/31/2024 $665,129.00
Celanie K Christensen Indiana University Health Renewal (not prev committed) Program for Children with Special Healthcare Needs - Riley Hospital 7/1/2023 6/30/2025 $335,027.00
D Wade Clapp U.s. Department Of Defense New Identifying and Testing Molecular Therapies for Schwannoma 7/1/2023 6/30/2026 $1,056,666.00
Susan Kim Conroy Indiana University Health New A Transcranial magnetic stimulation of the ventromedial prefrontal cortex to target neural connectivity and rumination in treatment-resistant major depressive disorder: a pilot study 7/1/2023 6/30/2026 $149,506.00
Timothy W Corson National Eye Institute New Long-acting formulations of griseofulvin for ocular neovascularization therapy 7/1/2023 3/31/2024 $523,302.00
Joanne K Daggy Heartland Health Research Alliance Ltd New Data Coordinating and Analytic (DCA) Core 10/1/2022 12/31/2023 $282,332.00
Paul Richard Dexter Regenstrief Institute, Inc. New Measuring the impact of Paxlovid on preventing healthcare utilization across the spectrum of care across different risk groups. 2/7/2023 3/31/2023 $27,499.00
Linda A DiMeglio Benaroya Research Institute At Virginia Mason Renewal (not prev committed) Immune Tolerance Network 2/1/2016 1/31/2023 $79,751.00
Matthew David Durbin National Heart, Lung And Blood Institute New "SHROOM3 is a Novel Cause of Congenital Heart Disease" 7/1/2023 6/30/2024 $155,248.00
Jeffrey J Easler University Of Pittsburgh New P-QST Project: Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis 7/1/2022 6/30/2023 $32,039.00
George J. Eckert University Of Michigan Renewal (not prev committed) Phase III RCT of the Effectiveness of Silver Diamine Fluoride in Arresting Cavitated Caries Lesions 2/1/2023 10/31/2023 $15,671.00
Tatiana M Foroud University Of California, San Diego New Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease 7/15/2022 6/30/2023 $88,343.00
Matthew L Friedman Boston Children's Hospital New Trial of Indication-based Transfusion of Red Blood Cells in ECMO 7/1/2022 6/30/2023 $16,040.00
Samir Kumar Gupta Massachusetts General Hospital New A5332: Randomized Trial to Prevent Vascular Events in HIV-REPRIEVE 5/1/2023 4/30/2024 $6,030.00
Flora Hammond Icahn School Of Medicine At Mount Sinai New Leveraging Nationwide Research Infrastructure to Enrich Brain Health After TBI: The ENRICH Brain Health Study 9/15/2022 9/14/2023 $24,000.00
Renzhi Han National Heart, Lung And Blood Institute New Base editing of ASGR1 for cardiovascular disease 4/17/2023 3/31/2024 $1,250.00
Renzhi Han National Heart, Lung And Blood Institute New ANO5 in Muscle Health and Disease 6/25/2023 3/31/2024 $225,340.00
Tamara S Hannon The Patachou Foundation Renewal (not prev committed) Pataschool Monitoring and Evaluation 6/1/2023 6/30/2024 $19,945.00
Chunhai Hao Ben & Catherine Ivy Foundation New Structural mechanism and glioblastoma therapy of SUMO1 small molecule degraders 7/1/2023 6/30/2025 $597,184.00
Al Hassanein Indiana University Health New Prevention of Post-Surgical Lymphedema with Prox-1 7/1/2023 6/30/2026 $106,000.00
Takashi Hato Grace M. Showalter Trust New 2023 Showalter Scholar - Takashi Hato 7/1/2023 6/30/2024 $25,000.00
Taiki Hayasaka American Physiological Society New The Novel Role of MicroRNA-150/Periostin Axis in Regulating Cardiac Fibroblast Activation During Myocardial Infarction 7/1/2023 6/30/2024 $50,000.00
Kerry Marie Hege Emory University New Hem EQUIPT VWD Program 8/1/2022 12/31/2023 $4,590.00
Sarah Morsbach Honaker Nationwide Children's Hospital New CE19-001, Injury Control Research Center (ICRC) - Preventive Infant Sleep Guidance in Black Families 8/1/2022 7/31/2023 $16,874.00
Yohan Jang University Of Maryland New Randomized Controlled Trial Comparing Antibiotic Cement BeadPouch Versus Negative-Pressure Wound Therapy for the Management of Severe Open TibiaFracture Wounds (VvB) 9/30/2022 9/29/2026 $11,000.00
Xiaoming Jin U.s. Army Medical Research Acquisition Activity New Prevention of posttraumatic epilepsy by inhibiting the initiation of innate immune reaction 7/1/2023 6/30/2026 $1,299,999.00
Mohammad Kalantar Society For Simulation In Healthcare New Independent contractor agreement 3/1/2022 1/22/2023 $15,000.00
Paul Ko American Medical Association New ASSESSMENT OF HEALTH SYSTEMS SCIENCE IN CLINICAL ENVIRONMENTS 6/7/2023 6/6/2024 $25,000.00
Jenna Kathleen Koenig American Brain Tumor Association New Targeting Temozolomide Resistance in GBM via AKT and MDM2 inhibition 6/1/2023 8/31/2023 $3,000.00
Diane Kuhn Grace M. Showalter Trust New Patient-Centeredness in Value-Based Emergency Care: A Mixed Methods Analysis of Patient Experience Data 7/1/2023 6/30/2024 $75,000.00
Alan P Ladd Riley Children's Foundation New Riley Children's Foundation #74-A8 Merrill S. Davis Lectureship Endowment 5/1/2023 6/30/2024 $1,534.66
Charly Lai National Heart, Lung And Blood Institute Renewal (not prev committed) Role of Skeletal Muscle in Pulmonary Vascular Remodeling 7/1/2023 6/30/2024 $721,088.00
Kaustubh Limaye Emory University New Endovascular Therapy for Low NIHSS Ischemic Strokes 4/28/2023 4/27/2025 $53,000.00
Amelia K Linnemann National Institute Of Diabetes, Digestive & Kidney New Beta Cell Heterogeneity in the Interferon Alpha Response 6/8/2023 6/7/2024 $47,694.00
Debra K Litzelman Indiana Department Of Health New My Healthy Baby: Exploring CHW Reimbursement 5/1/2023 12/31/2024 $109,659.50
Debra K Litzelman Purdue University New Community Health Worker Training Program (CHWTP) 9/15/2022 9/14/2025 $90,000.00
Krista J Longtin Indiana University Health New Harnessing Applied Improvisation to Restore Empathy and Connection in Stressed Emergency Departments; (HARriED Study) 7/1/2023 6/30/2025 $100,000.00
Americo Harry Lopez-Yglesias National Institute Allergy & Infectious Diseases New T-bet-regulated myeloid innate defense against Toxoplasma gondii 7/1/2023 6/30/2024 $315,000.00
Wei Luo National Institute Allergy & Infectious Diseases New The role of PTEN signaling in regulating germinal center B cell fate decision 6/26/2023 5/31/2024 $237,750.00
Roberto F Machado National Heart, Lung And Blood Institute Renewal (not prev committed) Vascular Targeting Genomic & Genetic Strategies for Acute Chest Syndrome 7/1/2023 6/30/2024 $753,340.00
Jessica Maiers National Institute Of Diabetes, Digestive & Kidney New Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis 7/1/2023 4/30/2024 $426,530.00
Larry Wayne Markham Riley Children's Foundation New Pediatric Cardiology Home Monitoring Care Program 5/1/2023 4/30/2024 $9,750.00
Hannah L Maxey Indianapolis Coalition For Patient Safety, Inc. New Indianapolis Coalition for Patient Safety 5/19/2023 6/23/2023 $3,047.00
Hannah L Maxey Indiana Department Of Health New Support for the Indiana Primary Care Needs Assessment 7/1/2023 3/31/2024 $11,395.00
Niki Messmore Serve Indiana New IUSM AmeriCorps 9/1/2023 8/31/2024 $228,571.00
Corinne E Metzger Grace M. Showalter Trust New Exploring impacts of opioids and alternate therapies on bone in CKD 7/1/2023 6/30/2024 $75,000.00
Allison Elizabeth Meyer Indiana University Health New Developing a Clinical Decision-Making Tool to Enhance the Appropriate Application of Telehealth Services for Youth and Families 7/1/2023 6/30/2026 $150,000.00
Kathy D. Miller Johns Hopkins University New P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No,Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer-Cohort A Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy,Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HR+ BreastCancer-Cohort B Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy,Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, Triple NegativeBreast Cancer 5/27/2023 5/26/2028 $259,139.53
Kathy D. Miller Johns Hopkins University New P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer -Cohort A Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HR+ Breast Cancer -Cohort B Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, Triple Negative Breast Cancer 5/25/2023 5/24/2028 $8,602.00
Kathy D. Miller Johns Hopkins University New P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No,Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer-Cohort A Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy,Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HR+ BreastCancer-Cohort B Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy,Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, Triple NegativeBreast Cancer 5/27/2023 5/26/2028 $259,139.53
Kathy D. Miller Johns Hopkins University New P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer-Cohort A Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HR+ Breast Cancer-Cohort B Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, Triple Negative Breast Cancer 5/27/2023 5/26/2028 $239,497.53
Kathy D. Miller Johns Hopkins University New P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer -Cohort A Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HR+ Breast Cancer -Cohort B Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, Triple Negative Breast Cancer 5/25/2023 5/24/2028 $8,602.00
Kathy D. Miller Johns Hopkins University New P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer-Cohort A Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HR+ Breast Cancer-Cohort B Sub-Protocol Title: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, Triple Negative Breast Cancer 5/27/2023 5/26/2028 $239,497.53
Jagannath Misra Grace M. Showalter Trust New Role of ZAK kinase in the activation of GCN2 kinase in response to stress 7/1/2023 6/30/2024 $75,000.00
Patrick O Monahan Heartland Health Research Alliance Ltd New Data Coordinating and Analytic (DCA) Core 10/1/2022 12/31/2023 $282,332.00
Amber L Mosley University Of Southern California New Investigating RNA Dysregulation in Neurological Disease Through Study of Pontocerebellar Hypoplasia Type 1b 4/15/2023 3/31/2024 $31,700.00
Roman M Natoli Center For Orthopaedic TraumaAdvancement New COTA Fellowship 2023-2024 8/1/2023 7/31/2024 $25,000.00
Roman M Natoli Aotrauma North America Renewal (not prev committed) 2023/2024 AO Trauma North America (AO TNA) Long-Term Fellowship Program 8/1/2023 7/31/2024 $60,000.00
Brittany Dawn Needham Grace M. Showalter Trust New Defining the Neurological Effects of Gut Microbial Tryptophan Metabolism 7/1/2023 6/30/2024 $75,000.00
Kenneth P Nephew Ovarian Cancer Alliance Of Greater Cincinnati New Epigenetic therapy to improve the response to platinum-based chemotherapy in ovarian cancer and prevent disease relapse and recurrence 6/5/2023 6/4/2024 $50,000.00
April D. Newton Indiana University Health New Team-based Collaborative Practice Training to Address Health Disparities and Inequities 7/1/2023 6/30/2025 $96,000.00
Heather M O'Hagan Ovarian Cancer Alliance Of Greater Cincinnati New Epigenetic therapy to improve the response to platinum-based chemotherapy in ovarian cancer and prevent disease relapse and recurrence 6/5/2023 6/4/2024 $50,000.00
Padmanabhan Pattabiraman Grace M. Showalter Trust New NOVEL INTRAOCULAR PRESSURE LOWERING STRATEGY TARGETING LIPID BIOGENESIS IN TRABECULAR MESHWORK 7/1/2023 6/30/2024 $75,000.00
Rachel Patzer National Institute Of Diabetes, Digestive & Kidney New Improving Quality and Access to Early Steps in Kidney Transplantation 5/1/2023 6/30/2024 $510,341.00
Rachel Patzer Regenstrief Institute, Inc. Renewal (not prev committed) Regenstrief 44-825-70 7/1/2023 6/30/2024 $1,381,273.00
Casey A Pederson Indiana University Health New Developing a Clinical Decision-Making Tool to Enhance the Appropriate Application of Telehealth Services for Youth and Families 7/1/2023 6/30/2026 $150,000.00
Nicholas R Pettit Indiana University Health New Developing an Intervention to Promote Lung Cancer Screening Among Underserved Individuals: A Mixed Methods Pilot Study 7/1/2023 6/30/2026 $106,000.00
Marian D Pfefferkorn Connecticut Children's Medical Center New Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease (CAMEO) 6/9/2023 6/8/2028 $141,250.00
Daniel V Runco Regents Of The University Of California New PNOC029: Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults 6/1/2023 5/31/2024 $15,000.00
Linda Marie Schutzman Grace M. Showalter Trust New Investigation of cellular adhesion molecules in pulmonary artery thrombosis following blunt thoracic trauma 7/1/2023 6/30/2024 $75,000.00
Emily K Sims Grace M. Showalter Trust New 2023 Showalter Scholar - Emily Sims 7/1/2023 6/30/2024 $25,000.00
Steven J. Steiner Cincinnati Children's Hospital Medical Center New Precise Infliximab Exposure and Pharmacodynamic Control to Achieve Deep Remission in Pediatric Crohn's Disease 6/1/2022 3/31/2024 $60,409.00
William J. Sullivan Grace M. Showalter Trust Renewal (not prev committed) Disrupting RNA modification as a novel treatment for parasitic infection 7/1/2023 6/30/2024 $60,000.00
Naomi B Swiezy Riley Children's Foundation New HANDs in Autism® Sarkine General Funds 5/1/2023 4/30/2025 $16,210.00
Konrad M Szymanski National Institute Of Diabetes, Digestive & Kidney New A patient-centered approach to urinary incontinence in adults with spina bifida 7/1/2023 6/30/2024 $118,875.00
Stacey Elaine Tarvin Childhood Arthritis And Rheumatology Research Alliance New Program Director, CTP Implementation Science Pilot for CARRA 7/1/2023 6/30/2026 $155,595.00
Jennifer Dawn Taylor Indiana Department Of Health New FY2024-25 Area Health Education Centers Operating Support 7/1/2023 6/30/2025 $4,461,352.00
Andrew Thomas Templin Grace M. Showalter Trust New Receptor interacting protein kinase signaling in beta-cell death and islet immune responses 7/1/2023 6/30/2024 $75,000.00
William Michael Tierney Regenstrief Institute, Inc. Renewal (not prev committed) Regenstrief 44-825-70 7/1/2023 6/30/2024 $1,381,273.00
Natasha Louise Tilston-Lunel Grace M. Showalter Trust New Comparative pathogenesis of OROV and OROV reassortants in a murine model 7/1/2023 6/30/2024 $75,000.00
Terry A Vik Moi University Faculty Of Health Sciences Renewal (not prev committed) The Multiple Myeloma Program-AMPATH 12/1/2022 11/30/2023 $35,526.00
Leslie Elaine Wagner National Institute Of Diabetes, Digestive & Kidney New Beta Cell Heterogeneity in the Interferon Alpha Response 6/8/2023 6/7/2024 $47,694.00
Jun Wan Grace M. Showalter Trust New 2023 Showalter Scholar - Jun Wan 7/1/2023 6/30/2024 $25,000.00
Nian Wang Grace M. Showalter Trust New Imaging Brain Connectome and Neuropathology of Alzheimer's Disease at Microscopic Resolution 7/1/2023 6/30/2024 $75,000.00
Yaoqi Alan Wang University Of Texas Md Anderson Cancer Center New (00015108)Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma 2/1/2023 1/31/2024 $100,000.00
Elizabeth Weinstein Indiana University Health New Harnessing Applied Improvisation to Restore Empathy and Connection in Stressed Emergency Departments; (HARriED Study) 7/1/2023 6/30/2025 $100,000.00
Ronald C. Wek Grace M. Showalter Trust Renewal (not prev committed) Translation and Stress Regulatory Pathways in Health and Disease 7/1/2023 6/30/2024 $60,000.00
Sarah Elizabeth Wiehe Indiana University Health Foundation New Advancing Cardiovascular Health Equity Through Community Partnerships 9/15/2022 9/14/2025 $1,141,369.00
Frank Yang National Institute Allergy & Infectious Diseases Renewal (not prev committed) Regulatory Network of the Lyme Disease Pathogen 6/5/2023 5/31/2024 $485,038.00
Default Author Avatar IUSM Logo
Author

IU School of Medicine

With more than 60 academic departments and specialty divisions across nine campuses and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, Indiana University School of Medicine is continuously advancing its mission to prepare healers and transform health in Indiana and throughout the world.

The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.